Chiglitazar (sodium)
Chiglitazar (Carfloglitazar) is a PPARα/γ dual agonist, with EC50s of 1.2, 0.08, 1.7 μM for PPARα, PPARγ and PPARδ, respectively.
Product Specifications
CAS Number
2390374-10-2
Product Name Alternative
Carfloglitazar (sodium)
UNSPSC
12352005
Target
PPAR
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Smiles
O=C(C1=CC=C(C=C1)F)C(C=CC=C2)=C2N[C@H](C(O[Na])=O)CC(C=C3)=CC=C3OCCN4C5=CC=CC=C5C6=CC=CC=C64
Molecular Formula
C36H28FN2NaO4
Molecular Weight
594.61
References & Citations
[1]Li PP, et al. The PPARalpha/gamma dual agonist chiglitazar improves insulin resistance and dyslipidemia in MSG obese rats. Br J Pharmacol. 2006 Jul;148 (5) :610-8.|[2]He BK, et al. In Vitro and In Vivo Characterizations of Chiglitazar, a Newly Identified PPAR Pan-Agonist. PPAR Res. 2012;2012:546548.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 3
Isoform
PPARα; PPARβ/δ; PPARγ
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC431620 20 µg
Argonaute 2 (AGO2) (NM_001164623) Human Over-expression Lysate
Sign In for Pricing
View Details 
TRC-A630332-1MG 1 mg
rac 2-Aminothiazoline-4-carboxylic Acid-13C,15N2
Sign In for Pricing
View Details